ONESTI, CONCETTA ELISA
 Distribuzione geografica
Continente #
NA - Nord America 1.799
AS - Asia 1.231
EU - Europa 687
SA - Sud America 180
AF - Africa 64
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.968
Nazione #
US - Stati Uniti d'America 1.748
SG - Singapore 394
HK - Hong Kong 235
IT - Italia 201
CN - Cina 180
VN - Vietnam 176
BR - Brasile 132
SE - Svezia 109
IN - India 105
DE - Germania 100
FI - Finlandia 64
FR - Francia 39
CA - Canada 35
GB - Regno Unito 32
JP - Giappone 31
RU - Federazione Russa 26
MA - Marocco 22
ZA - Sudafrica 22
AR - Argentina 19
PH - Filippine 18
IE - Irlanda 15
RO - Romania 14
NL - Olanda 12
PL - Polonia 12
EC - Ecuador 11
ID - Indonesia 11
KR - Corea 11
TR - Turchia 11
AT - Austria 10
MX - Messico 10
BD - Bangladesh 9
IQ - Iraq 9
TG - Togo 9
UA - Ucraina 9
BE - Belgio 7
BG - Bulgaria 7
CO - Colombia 7
ES - Italia 7
HU - Ungheria 6
AU - Australia 5
KZ - Kazakistan 4
MY - Malesia 4
NP - Nepal 4
PK - Pakistan 4
TH - Thailandia 4
VE - Venezuela 4
AL - Albania 3
CL - Cile 3
JO - Giordania 3
OM - Oman 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
IL - Israele 2
KE - Kenya 2
MK - Macedonia 2
TW - Taiwan 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
CG - Congo 1
EG - Egitto 1
GA - Gabon 1
GY - Guiana 1
IR - Iran 1
JM - Giamaica 1
LB - Libano 1
LT - Lituania 1
MC - Monaco 1
ML - Mali 1
MT - Malta 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
SC - Seychelles 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.968
Città #
Hong Kong 220
Ashburn 204
Singapore 197
Fairfield 174
San Jose 158
Woodbridge 88
Dallas 87
Chandler 74
Los Angeles 74
Cambridge 73
Rome 72
Seattle 66
Wilmington 63
Houston 61
Ho Chi Minh City 53
Hanoi 47
Munich 38
Beijing 33
San Paolo di Civitate 31
Princeton 30
Dearborn 28
New York 28
Santa Clara 26
Tokyo 26
Buffalo 25
Plano 25
Lauterbourg 21
Turku 21
Casablanca 20
Helsinki 19
Johannesburg 19
Lawrence 18
Ottawa 18
Frankfurt am Main 17
Dublin 16
Millbury 16
San Diego 16
The Dalles 15
Boston 14
Milan 14
Council Bluffs 13
Ann Arbor 12
Hillsboro 12
Da Nang 11
São Paulo 11
Cosenza 10
Jakarta 10
Haiphong 9
Lomé 9
Toronto 9
Warsaw 9
Falkenstein 8
Andover 7
Hefei 7
Norwalk 7
Redondo Beach 7
Sofia 7
Denver 6
Elk Grove Village 6
Fremont 6
Guangzhou 6
London 6
Shenzhen 6
Belo Horizonte 5
Brooklyn 5
Brussels 5
Chicago 5
Federal 5
Madrid 5
Phoenix 5
Sydney 5
Vienna 5
Ankara 4
Atlanta 4
Baghdad 4
Biên Hòa 4
Bremen 4
Guayaquil 4
Istanbul 4
Mannheim 4
Mexico City 4
Montreal 4
Nuremberg 4
Quito 4
Shanghai 4
Yubileyny 4
Almaty 3
Amman 3
Barnet 3
Budapest 3
Changsha 3
Córdoba 3
Dhaka 3
Florence 3
Fuzhou 3
Hyderabad 3
Hải Dương 3
Indiana 3
Moscow 3
Muscat 3
Totale 2.582
Nome #
A nomogram to predict 5-fluorouracil toxicity: when pharmacogenomics meets the patient 193
Continuous, low-dose capecitabine for patients with recurrent colorectal cancer 192
Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes 183
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX 179
Degradation rate of 5-fluorouracil in metastatic colorectal cancer. A new predictive outcome biomarker? 176
Molecular detection of EMT markers in circulating tumor cells from metastatic non-small cell lung cancer patients. Potential role in clinical practice 162
Evaluation of 5-fluorouracil degradation rate and pharmacogenetic profiling to predict toxicity following adjuvant capecitabine 160
Genetic polymorphism can help physician choosing the best lung cancer chemotherapy 140
Crizotinib plus radiotherapy in brain oligoprogressive NSCLC ROS1 rearranged and PD-L1 strong 139
P0158 Relation between polymorphisms and chemotherapy in lung cancer 137
Prognosis of elderly gastric cancer patients after surgery: a nomogram to predict survival 137
What to expect from high throughput genomics in metastatic breast cancers? 129
Gastric Metastases From Testicular Cancer: Case Report and Review of Literature 124
Hyperprogressive disease and early hypereosinophilia after anti-PD-1 treatment. a case report 122
Breast Metastasis of Thymic Carcinoma 113
Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients 113
107P Treatment landscape in SDH-deficient gastrointestinal stromal tumors: A systematic review and meta-analysis 104
Sjögren syndrome induced by anti PDL-1 treatment for TNBC: case report and review of literature 101
Esophageal stenosis: a differential diagnosis between esophageal cancer and metastasis from other neoplasia 100
A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer 100
Quality of life and emotional distress in sarcoma patients diagnosed during COVID-19 pandemic: a supplementary analysis from the SarCorD study 99
Unexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated with multimodal treatment: A single-center experience and review of the literature 99
126P Efficacy and safety of metronomic cyclophosphamide across sarcoma subtypes: A retrospective analysis in a referral centre 96
A rare case of palatin tonsillar metastasis from small cell lung cancer 94
The use of bevacizumab in non-small cell lung cancer: an update 91
Pharmacogenomics in lung cancer chemotherapy: a review of what the oncologist should know. 88
High-doses of proton pump inhibitors in refractory gastro-intestinal cancer: A case series and the state of art 85
The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer 81
null 68
Evolving treatments for advanced gastric cancer: appraisal of the survival trend 68
Long term outcomes of breast primary sarcomas and malignant phyllodes tumors: 20 years observational analysis of the BEAM∗ study group. (∗the breast European association for mesenchymal tumors) 62
null 61
null 56
null 52
null 46
null 46
null 42
Recent advances for the treatment of pancreatic and biliary tract cancer after first-line treatment failure 40
Precision medicine for metastatic breast cancer 38
Totale 4.116
Categoria #
all - tutte 10.991
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.991


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 0 0 0 0 13 6
2021/2022307 2 10 22 14 43 16 7 34 18 26 53 62
2022/2023345 65 85 22 31 37 27 14 15 22 1 18 8
2023/2024138 13 23 3 10 12 25 5 9 1 15 9 13
2024/2025704 0 29 17 37 18 32 33 31 98 76 79 254
2025/20261.696 170 135 137 140 201 71 350 64 177 178 73 0
Totale 4.116